X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-15 | BCAX | Cohlhepp Ryan | Pres, COO | S - Sale+OE | $18.16 | -12,500 | 198,141 | -6% | -$226,943 | |||||
| DM | 2025-10-13 | BCAX | Mazumdar Claire | CEO | S - Sale+OE | $18.88 | -24,734 | 309,892 | -7% | -$466,936 | |||||
| D | 2025-10-09 | BCAX | Raben David | Chief Medical Officer | S - Sale+OE | $18.45 | -22,000 | 35,497 | -38% | -$405,900 | |||||
| D | 2025-10-09 | BCAX | Hyep Ivan | CFO | S - Sale+OE | $18.23 | -6,415 | 145,355 | -4% | -$116,931 | |||||
| DM | 2025-10-06 | BCAX | Hyep Ivan | CFO | S - Sale+OE | $18.21 | -30,385 | 145,355 | -17% | -$553,198 | |||||
| DM | 2025-10-06 | BCAX | Cohlhepp Ryan | Pres, COO | S - Sale+OE | $18.06 | -50,500 | 202,641 | -20% | -$911,842 | |||||
| D | 2025-09-29 | BCAX | Meisner Lara | GC | S - Sale+OE | $14.75 | -33,807 | 0 | -100% | -$498,653 | |||||
| D | 2025-09-15 | BCAX | Meisner Lara | GC | S - Sale+OE | $11.49 | -15,829 | 0 | -100% | -$181,875 | |||||
| D | 2025-06-16 | BCAX | Meisner Lara | GC | S - Sale+OE | $10.43 | -15,829 | 0 | -100% | -$165,096 | |||||
| D | 2025-03-14 | BCAX | Meisner Lara | GC | S - Sale+OE | $12.90 | -79,146 | 0 | -100% | -$1,021,211 | |||||
| D | 2024-09-16 | BCAX | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $18.00 | +1,833,000 | 2,652,575 | +224% | +$32,994,000 | |||||
| D | 2024-09-17 | BCAX | Flynn James E | Possible Members of 10% Group, 10% | P - Purchase | $18.00 | +70,000 | 1,795,174 | +4% | +$1,260,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |